A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathway
一项针对转移性胰腺导管腺癌的窗口期试验揭示了靶向KRAS-MEK通路治疗的耐药机制。
期刊:
影响因子:
doi:10.64898/2025.12.12.693851
Tsuda, Motoyuki; Keith, Dove; Daniel, Colin J; Pelz, Carl; Blise, Katie E; Ozmen, Tugba Y; Ozmen, Furkan; Hawthone, Kevin; Eng, Jennifer R; Li, Xi; Wang, Xiaoyan; Zimny, Hayley; Sivagnanam, Shamilene; Betre, Konjit; Kirchberger, Nell; Chong, Benson; Lee, Jinho; Matter, Aubry; Smith, Alexander; Agritelley, Ethan S; Waugh, Trent; Sannecy, Ashwin; Alarcon, Kimberly; Youm, Isaac; Protzek, Sara; Egger, Julian; English, Isabel A; Yang, Min; Shah, Vidhi M; Link, Jason M; Creason, Allison L; Worth, Patrick J; Goodyear, Shaun M; Chin, Koei; Muschler, John L; Suciu, Christopher G; Corless, Christopher L; Cao, Sha; Soucek, Laura; Kardosh, Adel; Coussens, Lisa M; Brody, Jonathan R; Lopez, Charles D; Mills, Gordon B; Sears, Rosalie C